Skip to main content
Journal cover image

Supplement use among men with prostate cancer.

Publication ,  Journal Article
Wiygul, JB; Evans, BR; Peterson, BL; Polascik, TJ; Walther, PJ; Robertson, CN; Albala, DM; Demark-Wahnefried, W
Published in: Urology
July 2005

OBJECTIVES: To characterize supplement use within a sample population of men diagnosed with prostate cancer. METHODS: A census of men diagnosed with prostate cancer at Duke University Medical Center from 1997 to 2002 (n = 1402) was mailed a survey that ascertained data on health status, education, diet, exercise, smoking status, and information on supplement use. Differences between demographic and treatment subgroups were described and tested, as was change in supplement use after diagnosis. RESULTS: Data from 805 respondents indicated that a majority (73%) used supplements, and 68% claimed that this information was shared with their cancer care provider. The most commonly reported supplements were multivitamins (56%), vitamin E (43%), vitamin C (33%), and calcium (26%). On average, 2.7 +/- 2.8 supplements per day were taken, and use increased significantly after diagnosis for most supplements. Use was significantly higher among men who were white (P = 0.043), were more highly educated (P = 0.002), exercise regularly (P = 0.020), and who consume five or more daily servings of fruits and vegetables (P = 0.040). CONCLUSIONS: A high percentage of men with prostate cancer take supplements, especially those who are white, more educated, and who pursue healthful behaviors. Systematic means of capturing these data are necessary to begin to understand the potential impact of supplements on disease outcome, especially because no data exist to suggest that supplements are of any benefit after diagnosis.

Duke Scholars

Published In

Urology

DOI

EISSN

1527-9995

Publication Date

July 2005

Volume

66

Issue

1

Start / End Page

161 / 166

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Surveys and Questionnaires
  • Prostatic Neoplasms
  • Middle Aged
  • Male
  • Humans
  • Dietary Supplements
  • Aged
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wiygul, J. B., Evans, B. R., Peterson, B. L., Polascik, T. J., Walther, P. J., Robertson, C. N., … Demark-Wahnefried, W. (2005). Supplement use among men with prostate cancer. Urology, 66(1), 161–166. https://doi.org/10.1016/j.urology.2005.01.035
Wiygul, Jeremy B., Brian R. Evans, Bercedis L. Peterson, Thomas J. Polascik, Philip J. Walther, Cary N. Robertson, David M. Albala, and Wendy Demark-Wahnefried. “Supplement use among men with prostate cancer.Urology 66, no. 1 (July 2005): 161–66. https://doi.org/10.1016/j.urology.2005.01.035.
Wiygul JB, Evans BR, Peterson BL, Polascik TJ, Walther PJ, Robertson CN, et al. Supplement use among men with prostate cancer. Urology. 2005 Jul;66(1):161–6.
Wiygul, Jeremy B., et al. “Supplement use among men with prostate cancer.Urology, vol. 66, no. 1, July 2005, pp. 161–66. Pubmed, doi:10.1016/j.urology.2005.01.035.
Wiygul JB, Evans BR, Peterson BL, Polascik TJ, Walther PJ, Robertson CN, Albala DM, Demark-Wahnefried W. Supplement use among men with prostate cancer. Urology. 2005 Jul;66(1):161–166.
Journal cover image

Published In

Urology

DOI

EISSN

1527-9995

Publication Date

July 2005

Volume

66

Issue

1

Start / End Page

161 / 166

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Surveys and Questionnaires
  • Prostatic Neoplasms
  • Middle Aged
  • Male
  • Humans
  • Dietary Supplements
  • Aged
  • 3202 Clinical sciences
  • 1103 Clinical Sciences